| Metabolomics and Mass Spectrometry Studies | Lifetime | 27 | CN 1 | 99.71 |
| Pharmacological Effects of Natural Compounds | Lifetime | 33 | CN 7 | 99.49 |
| Gut microbiota and health | Lifetime | 74 | CN 5 | 99.67 |
| Ginseng Biological Effects and Applications | Lifetime | 25 | CN 15 | 99.28 |
| Traditional Chinese Medicine Analysis | Lifetime | 31 | CN 27 | 99.39 |
| Drug Transport and Resistance Mechanisms | Lifetime | 113 | CN 1 | 99.36 |
| Liver Disease Diagnosis and Treatment | Lifetime | 375 | CN 14 | 99.45 |
| Traditional Chinese Medicine Studies | Lifetime | 61 | CN 44 | 97.94 |
| Diet and metabolism studies | Lifetime | 523 | CN 8 | 99.03 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 463 | CN 28 | 98.71 |
| Phytoestrogen effects and research | Lifetime | 398 | CN 23 | 94.78 |
| Forensic Toxicology and Drug Analysis | Lifetime | 516 | CN 6 | 93.59 |
| Plant-based Medicinal Research | Lifetime | 863 | CN 244 | 88.02 |
| Sphingolipid Metabolism and Signaling | Lifetime | 981 | CN 32 | 88.69 |
| Psychedelics and Drug Studies | Lifetime | 655 | CN 6 | 85.48 |
| Medicinal Plant Pharmacodynamics Research | Lifetime | 473 | CN 315 | 77.97 |
| Herbal Medicine Research Studies | Lifetime | 771 | CN 48 | 76.09 |
| Nephrotoxicity and Medicinal Plants | Lifetime | 789 | CN 137 | 67.38 |
| Melamine detection and toxicity | Lifetime | 683 | CN 273 | 38.92 |
| Drug Transport and Resistance Mechanisms | 2021-2025 | 3 | CN 1 | 99.43 |
| Metabolomics and Mass Spectrometry Studies | 2021-2025 | 14 | CN 3 | 98.87 |
| Gut microbiota and health | 2021-2025 | 58 | CN 28 | 99.24 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 138 | CN 12 | 99.25 |
| Diet and metabolism studies | 2021-2025 | 128 | CN 13 | 98.34 |
| Aquatic Ecosystems and Phytoplankton Dynamics | 2021-2025 | 105 | CN 70 | 95.67 |
| Microbial Community Ecology and Physiology | 2021-2025 | 481 | CN 249 | 94.62 |
| Epigenetics and DNA Methylation | 2021-2025 | 892 | CN 334 | 90.64 |
| Forensic Toxicology and Drug Analysis | 2021-2025 | 102 | CN 4 | 92.49 |
| Diet, Metabolism, and Disease | 2021-2025 | 401 | CN 58 | 90.21 |
| Pharmacological Effects and Toxicity Studies | 2021-2025 | 290 | CN 17 | 90.80 |
| Alcohol Consumption and Health Effects | 2021-2025 | 271 | CN 23 | 90.15 |
| Potato Plant Research | 2021-2025 | 170 | CN 51 | 84.89 |
| Pediatric Hepatobiliary Diseases and Treatments | 2021-2025 | 927 | CN 125 | 79.25 |
| Peroxisome Proliferator-Activated Receptors | 2021-2025 | 388 | CN 133 | 72.98 |
| Pharmacogenetics and Drug Metabolism | 2021-2025 | 588 | CN 82 | 76.83 |
| Amino Acid Enzymes and Metabolism | 2021-2025 | 340 | CN 81 | 73.94 |
| Cholesterol and Lipid Metabolism | 2021-2025 | 298 | CN 60 | 72.69 |
| Plant Genetic and Mutation Studies | 2021-2025 | 551 | CN 81 | 64.64 |
| Fibroblast Growth Factor Research | 2021-2025 | 720 | CN 212 | 61.99 |
| Psychedelics and Drug Studies | 2021-2025 | 782 | CN 12 | 60.79 |
| Kruppel-like factors research | 2021-2025 | 637 | CN 246 | 56.00 |
| Plant-based Medicinal Research | 2021-2025 | 832 | CN 580 | 39.68 |
